Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

The British Journal of Dermatology
K AbuabaraJ M Gelfand

Abstract

Severe psoriasis is associated with excess mortality and increased risk of cardiovascular death. Population-based data evaluating cause-specific mortality in patients with psoriasis are limited. To describe cause-specific mortality in patients with severe psoriasis. We performed a cohort study from 1987 to 2002 of patients ≥18 years using the General Practice Research Database. We compared patients with a psoriasis code and a history of systemic therapy consistent with severe psoriasis (n=3603) with patients with no history of psoriasis (n=14,330). Age- and sex-adjusted Cox models were created for each of the leading causes of death defined by the Centers for Disease Control. Patients with severe psoriasis were at increased risk of death from cardiovascular disease [hazard ratio (HR) 1·57, 95% confidence interval (CI) 1·26-1·96], malignancies (HR 1·41, 95% CI 1·07-1·86), chronic lower respiratory disease (HR 2·08, 95% CI 1·24-3·48), diabetes (HR 2·86, 95% CI 1·08-7·59), dementia (HR 3·64, 95% CI 1·36-9·72), infection (HR 1·65, 95% CI 1·26-2·18), kidney disease (HR 4·37, 95% CI 2·24-8·53) and unknown/missing causes (HR 1·43, 95% CI 1·09-1·89). The absolute and excess risk of death was highest for cardiovascular disease (61·9 and...Continue Reading

References

Jan 1, 1989·Dermatologica·B Lindegård
Mar 1, 1993·International Journal of Dermatology·M A GuptaC N Ellis
Oct 12, 1996·BMJ : British Medical Journal·P O'Neill, P Kelly
Mar 25, 2000·Clinical and Experimental Dermatology·E Higgins
Oct 29, 2000·The Journal of Dermatology·J C Szepietowski, T Szepietowski
Apr 16, 2004·The Journal of Investigative Dermatology. Symposium Proceedings·John de KorteJan D Bos
May 1, 2004·European Journal of Epidemiology·Lotus MallbrisMona Ståhle-Bäckdahl
Jul 15, 2004·The Australasian Journal of Dermatology·Paul A J RussoAlan J Cooper
Feb 15, 2005·Annals of the Rheumatic Diseases·R G B LangleyC E M Griffiths
Dec 14, 2005·American Journal of Clinical Dermatology·Alexa B KimballYing Wu
Dec 21, 2005·Archives of Dermatology·Cristina FortesDamiano Abeni
Jun 3, 2006·The Journal of Investigative Dermatology·Joel M GelfandAndrea B Troxel
Oct 6, 2006·Archives of Dermatological Research·Dorothea M SommerMichael Weichenthal
Oct 13, 2006·JAMA : the Journal of the American Medical Association·Joel M GelfandAndrea B Troxel
Oct 21, 2006·Journal of the American Academy of Dermatology·Andrea L NeimannJoel M Gelfand
Jan 17, 2007·The British Journal of Dermatology·R J LudwigW-H Boehncke
May 1, 2007·Lancet·Julian L Burton, James Underwood
Dec 19, 2007·Archives of Dermatology·Joel M GelfandBrian L Strom
Dec 19, 2007·Archives of Dermatology·Consuelo HuertaLuis A García Rodríguez
Mar 4, 2008·Journal of the American Academy of Dermatology·Alexa B KimballUNKNOWN National Psoriasis Foundation
Mar 6, 2008·Dermatologic Therapy·Judith HongJohn Koo
Mar 12, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·A D CohenJ Meyerovitch
Jun 6, 2008·Current Opinion in Rheumatology·Rahat S Azfar, Joel M Gelfand
Jul 22, 2008·The British Journal of Dermatology·J DreiherA D Cohen
Sep 11, 2008·The British Journal of Dermatology·Y B BrauchliC R Meier
Nov 22, 2008·Journal of the American Academy of Dermatology·Shanu Kohli Kurd, Joel M Gelfand
May 22, 2009·The Journal of Investigative Dermatology·Joel M GelfandAndrea B Troxel
Jul 31, 2009·Postgraduate Medicine·Abby S Van Voorhees, Richard Fried
Sep 16, 2009·Gerontology·Benjamin Brian Alexander McNaullAnthony Peter Passmore
Oct 23, 2009·Dermatologic Therapy·Erica Dommasch, Joel M Gelfand
Oct 30, 2009·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Jen-Hau ChenYen-Ching Chen
Nov 21, 2009·American Journal of Hypertension·Michiaki NagaiKazuomi Kario
Dec 5, 2009·The American Journal of Medicine·Alice B Gottlieb, Frank Dann
Jan 19, 2010·British Journal of Clinical Pharmacology·Emily HerrettAndrew J Hall
Jan 27, 2010·The Mount Sinai Journal of Medicine, New York·Dara L DicksteinPatrick R Hof
Mar 6, 2010·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Nada F KhanPeter W Rose
Apr 27, 2010·Dermatologic Therapy·Luigi Naldi, Santo Raffaele Mercuri
Apr 27, 2010·Dermatologic Therapy·Paolo GisondiGiampiero Girolomoni
Apr 27, 2010·Dermatologic Therapy·Jennifer Hayes, John Koo
May 1, 2010·Seminars in Cutaneous Medicine and Surgery·Noori KimAlan Menter
May 15, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·S PreyJ-P Ortonne

❮ Previous
Next ❯

Citations

Aug 13, 2013·Zeitschrift für Rheumatologie·W-H Boehncke, S Boehncke
Feb 5, 2013·Archives of Dermatological Research·Johannes WohlrabMichael P Schön
Feb 24, 2012·Clinical Reviews in Allergy & Immunology·David SiegelIshwarlal Jialal
Nov 28, 2013·Nature Reviews. Nephrology·Christopher K Farmer, Paul E Stevens
Aug 24, 2013·Journal of Translational Medicine·Nehal N MehtaCarrie Brodmerkel
Jul 4, 2012·The Journal of Rheumatology. Supplement·Joel M Gelfand, Howa Yeung
Oct 1, 2013·Molecular Diagnosis & Therapy·Tiago TorresRosita Saraceno
Aug 29, 2013·Indian Dermatology Online Journal·Sridhar Jandhyala
Feb 15, 2014·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Tiago Torres, Nuno Bettencourt
Nov 22, 2014·Dermatologic Clinics·Marisa Kardos Garshick, Alexa Boer Kimball
Nov 22, 2014·Dermatologic Clinics·Caitriona Ryan, Brian Kirby
Apr 18, 2015·The Journal of Dermatological Treatment·Neil J KormanMary Helen Tran
Nov 14, 2013·The Journal of Dermatological Treatment·Lluís PuigHeinz Drexel
Feb 13, 2016·The British Journal of Dermatology·Z K Jabbar-LopezN J Reynolds
Sep 19, 2012·Journal of Dermatological Science·Cheng-Che E LanGwo-Shing Chen
Apr 16, 2011·The Journal of Investigative Dermatology·Joel M GelfandSinéad M Langan
Nov 25, 2011·The Journal of Investigative Dermatology·Sinéad M LanganJoel M Gelfand
Jul 17, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·M-A RichardC Paul
Jul 17, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·M-A Richard, C Paul
Nov 16, 2010·The British Journal of Dermatology·N M SeminaraJ M Gelfand
Nov 6, 2010·The British Journal of Dermatology·S R Feldman
Mar 6, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·U Mrowietz
Mar 6, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·K Reich
Oct 22, 2011·The British Journal of Dermatology·P GisondiG Girolomoni
Apr 16, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·U MrowietzK Reich
May 25, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·E PapadavidD Rigopoulos
Jul 28, 2012·The British Journal of Dermatology·P De MozziG A Johnston
Aug 14, 2013·The British Journal of Dermatology·E MahéUNKNOWN GEM Resopso
Apr 9, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·J J WuL J Herrinton
Nov 8, 2014·Photodermatology, Photoimmunology & Photomedicine·Sylvie Mireille FrankenThomas Rustemeyer
Jul 27, 2011·The American Journal of Medicine·Nehal N MehtaJoel M Gelfand
Jul 21, 2015·Journal of the American Academy of Dermatology·Hsien-Yi ChiuTsen-Fang Tsai
Dec 11, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·F RenczL Gulácsi
Jun 10, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·E SalahadeenO Ahlehoff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.